Clinical Trial Update: A Study of HLX07 + HLX10 With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line sqNSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating HLX07 + HLX10 with or without chemotherapy versus HLX10 with chemotherapy in first-line squamous non-small-cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• HLX07 (HLX07)
• HLX10

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Squamous Non-small-cell Lung Cancer | Phase 2 | Status: UNKNOWN